Methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate
C19H22ClFN6O2 — CID 163731517
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate
Methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate (PubChem CID 163731517) has the molecular formula C19H22ClFN6O2 and a molecular weight of 420.88 g/mol. Its IUPAC name is methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate |
|---|---|
| PubChem CID | 163731517 |
| Molecular Formula | C19H22ClFN6O2 |
| Molecular Weight | 420.88 g/mol |
| Exact Mass | 420.15 |
| IUPAC Name | methyl N-[2-[[2-(5-chloro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoropyrimidin-4-yl]amino]cyclohexyl]carbamate |
| SMILES | COC(=O)NC1CCCCC1Nc1nc(C2CNc3ncc(Cl)cc32)ncc1F |
| InChI | InChI=1S/C19H22ClFN6O2/c1-29-19(28)26-15-5-3-2-4-14(15)25-18-13(21)9-24-17(27-18)12-8-23-16-11(12)6-10(20)7-22-16/h6-7,9,12,14-15H,2-5,8H2,1H3,(H,22,23)(H,26,28)(H,24,25,27) |
| InChIKey | KZYDULFCSALFMN-UHFFFAOYSA-N |
| XLogP | 3.30 |
| TPSA | 101.06 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.88 |
| LogP ≤ 5 | 3.30 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163731517 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.